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<a/c>Abstract: Where suitable, dental implants are praised as a method of 
providing fixed solutions with the greatest longevity, and providing greatly 
improved retention for removable prostheses, resulting in increased levels of 
patient satisfaction and quality of life. 
However, with increasing evidence of long-term follow-up, there is a growing 
recognition of the susceptibility of dental implants to peri-implant diseases; 
peri-mucositis and peri-implantitis. This paper discusses the features of peri-
implant disease and important aspects of assessment criteria. 
<a/c>CPD/Clinical Relevance: This paper highlights the importance of 
supportive maintenance care for patients with dental implants, as well as the 
features and assessment of peri-implant disease. 
<b/f>Patient demand for dental implants as tooth replacements has increased 
rapidly over the decades and there are now a wide range of centres providing 
implant treatments. Dental implants are subject to failure, however, and dental 
practitioners should be prepared to monitor dental implants for disease and 
failure such that appropriate management can be implemented. This paper will 
present an overview of peri-implant diseases including peri-implant mucositis and 
peri-implantitis and assessment criteria based on current guidelines and 
evidence. 
<ch1/1>Mucosa at teeth and implants in health 
The peri-implant mucosa provides an important biological barrier which protects 
the rigid fixation of the implant to the bone from factors released from plaque 
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and the oral environment. This soft tissue attachment to the coronal portion of 
an implant is necessary for the maintenance of osseointegration and long term 
survival of dental implants.  
Clinically, peri-implant health is characterized by the absence of erythema, 
bleeding on probing, swelling, and suppuration.1 In health there are no visual 
differences between peri-implant and periodontal tissues, however, 
histologically a number of distinctions can be made (Figure 1)DELETE. The peri-
implant mucosa is lined by keratinized oral epithelium on the outer aspect, which 
is continuous with the sulcular epithelium, and a junctional epithelium which 
attaches to the implant surface by hemi-desmosomal attachment. The junctional 
epithelium is approximately 2 mm long. The underlying connective tissue is 
collagen rich, with fewer vascular structures and fibroblasts than that in its 
periodontal counterpart. The peri-implant tissues lack a periodontal ligament, 
and derive blood supply from the supra periosteal vessels only. Collagen fibres 
tend to run in a direction parallel to the implant surface and are said to offer 
less resistance to irritation and inflammatory effects than that around natural 
teeth.2,3 
The microflora that establishes in the healthy peri-implant sulcus is comparable 
to that found on adjacent teeth in health. Once an abutment is connected to the 
implant, salivary proteins and other substances soon form a pellicle similar to 
that on natural teeth. The microbial communities that colonize the site are 
characterized by gram-positive cocci and small numbers of gram-negative 
species.4 In health, there exists a homeostasis between the peri-implant tissues 
and the microbial biofilm, comparable to that of the gingival sulcus in health 
(Table 1). 
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Peri-implant Mucosa Periodontium 
Direct bone to implant contact 
(osseointegration) 
Presence of cementum and periodontal 
ligament  
More collagen fibres, fewer 
fibroblasts, less vascular 
More fibroblasts and more vascular 
Connective tissue fibres run parallel to 
implant surface without insertion, 
creating a ‘cuff’ around the implant 
Multiple orientations of connective 
tissue fibres, insertion of fibres into 
root cementum 
Table 1. Comparison of peri-implant mucosa with physiological periodontium 
 
<ch1/1>Peri-implant diseases 
Peri-implant diseases include peri-implant mucositis and peri-implantitis. These 
diseases have been likened to gingivitis and periodontitis, respectively, in that 
peri-mucositis represents a reversible, contained inflammation around the 
dental implant whereas peri-implantitis is associated with the irreversible loss 
of attachment and surrounding alveolar bone. The prevalence of peri-implantitis 
is reported to affect 10% of implants and 20% of patients over a minimum of 5 
years,5 but might range from 6.6%−36.6% of implants and 11.2%− 47.1% of 
patients.6 The prevalence of peri-implant mucositis is higher than that of peri-
implantitis; occurring in about 50% of implants and just under 80% of patients.7 
Each will be discussed in more detail below. 
<ch1/1>Peri-implant mucositis 
Biofilm accumulation in the peri-implant sulcus can disrupt the host–microbe 
homeostasis, resulting in a shift towards microbial communities which are 
inclined to favour and contribute towards inflammatory conditions, resulting 
clinically in a lesion known as peri-implant mucositis.6,8 
Features of peri-implant mucositis include erythema and bleeding on probing, 
with or without increased pocket depths, but without any loss of supporting 
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bone. Clinically, in terms of presentation, diagnosis and treatment, it is 
comparable to chronic gingivitis and is reversible.9 On a biological level, the 
immune-inflammatory response has been suggested to be more intense in peri-
implant mucositis than gingivitis, with greater increases in matrix 
metalloproteinase 8 and interleukin-1β in the crevicular fluid from implants, as 
compared with that from teeth,10 although the size of the inflammatory 
infiltrate does not appear to be significantly different.11 
There is some suggestion that a higher prevalence of peri-implant mucositis is 
associated with patients with mucosal diseases such as oral lichen planus and 
gingival desquamation, however, it is difficult to say whether this is due to the 
conditions or higher plaque scores that might be associated with them12−15 as 
evidence remains limited. 
Because such lesions are considered a precursor for peri-implantitis, the clinical 
implication is that peri-implant mucositis should be prevented and managed 
through optimal biofilm removal and addressing risk factors where 
possible.12,16,17 
<ch1/1>Peri-implantitis 
In susceptible patients, where peri-implant mucositis lesions are persistent, the 
inflammatory lesion can become extensive. A large inflammatory infiltrate 
consisting of plasma cells, macrophages and neutrophils1,18 starts to spread in an 
apical direction, beyond the junctional epithelium and connective tissue to 
involve the peri-implant crestal bone.19 The host response mediates bone 
resorption and loss of clinical attachment. Once clinical attachment loss is 
detectable, these lesions are then termed peri-implantitis. 
According to the 2017 World Workshop,1 the diagnosis of peri-implantitis 
requires: 
• Presence of bleeding and/or suppuration on gentle probing; 
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• Increased probing depth compared to previous examinations (probing 
depths of ≥6 mm in the absence of previous data); 
• Presence of bone loss beyond crestal bone level changes resulting from 
initial bone remodelling (bone loss ≥3 mm in the absence of previous data). 
In a similar fashion to periodontal disease, increasing depths of peri-implant 
pockets are associated with increasingly dysbiotic biofilms20 in which the 
occurrence and frequency of periodontal pathogens, such as Porphyromonas 
gingivalis and Aggregatibacter actinomycetemcomitans, are similar to those in 
periodontal disease. However, peri-implantitis lesions also harbour bacteria 
distinct from the microbiota typically associated with periodontal disease, such 
as Campylobacter, Eubacterium, Prevotella, Campylobacter, Treponema and 
Staphylococcus.10,21 Resistance to at least one antimicrobial substance has been 
reported in numerous peri-implant biofilms.22,23 In particular, Staphylococcus 
aureus appears to play a predominant role for the development of a peri-
implantitis, showing a high affinity to titanium and being closely linked to deep 
pockets with suppuration and bleeding on probing.24,25 
In comparison to periodontal lesions, peri-implantitis shows greater numbers of 
inflammatory mediators and increased osteoclasts.1 It seems that the pathology 
associated with peri-implantitis tends to progress more rapidly and in a non-
linear pattern.19,26 In part, the explanation might be found with the anatomical 
differences between peri-implant and periodontal tissues.27 In periodontitis, a 
connective tissue capsule is present between the base of the inflammatory 
lesion and the bone, but is absent in peri-implantitis.19,27 It may be that this 
tissue barrier serves to limit the apical extent of the lesion to some degree. 
Furthermore, the progression of the lesion may also be affected by differences 
in vascularity. The absence of a periodontal ligament in implant lesions means 
that vascular supply is comparatively diminished in the zone between the 
alveolar crest and the base of the junctional epithelium. It is likely that the 
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flow of infiltrating immune cells and growth factors to the lesion would be slow 
compared to periodontitis cases.2,6 The roughness of the implant surface might 
also be a contributing factor towards the progression of the lesion, rougher 
surfaces being more plaque retentive and establishing a biofilm which is more 
difficult to disturb.28 
<ch1/1>Foreign body reaction 
It has been suggested that a chronic foreign body reaction is inevitable around 
dental implants.29 Whereas the periodontal complex is the result of evolution, 
the soft-tissue barrier around implants is akin to an induced scar tissue 
response. Albrektsson et al consider osseointegration itself to be the result of 
a foreign body reaction, which results in osseous encapsulation to shield off the 
implant from the tissues. This results in direct bone–implant contact and the 
establishment of a dense zone of bone surrounding the implant which has less 
vasculature relatively compared to surrounding bone. They suggested that, in 
health, an equilibrium exists between the hard and soft tissues and the implant 
foreign body.29 The term osseoseparation30 has been used to describe marginal 
bone loss caused predominantly by immune osteoclastic activity following 
disturbance of an equilibrium between the host and implant ‘foreign body’, 
rather than being initiated by an infective or inflammatory process.31 This 
foreign body response might act in combination with inflammation or 
superimposing infection to define the final distance that bone is resorbed from 
around the implant, so that what is resorbed may be predominantly, if not 
exclusively, the foreign body bone, whereas resorption of the properly 
vascularized host bone is potentially lacking. 
<ch1/1>Risk factors 
A range of factors have been suggested as risk indicators for periodontal 
disease, with varying levels of supporting evidence. There is stronger evidence 
that there is an increased risk of developing peri‐implantitis in patients who 
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have a history of chronic periodontitis, poor plaque control skills, and no regular 
maintenance care after implant therapy.18 
There is some limited evidence linking peri‐implantitis to other factors, such as 
post‐restorative presence of submucosal cement, lack of peri‐implant 
keratinized mucosa, and positioning of implants that make it difficult to 
perform oral hygiene and maintenance.18 
It is suggested that peri-implant keratinized mucosa, occlusal overload, titanium 
particles, bone compression necrosis, overheating, micromotion and biocorrosion 
may be associated with the development of peri-implant disease, but strong 
evidence for these is lacking.1  
Risk factors include: 
• Plaque accumulation; and 
• Host susceptibility. 
<ch2/1>Plaque accumulation 
• Poor oral hygiene; 
• Non-enrolment on supportive maintenance programmes; 
• Non-keratinized peri-implant tissue; 
• Extrusion of excess cement; 
• Implants placed in close proximity making cleaning difficult; 
• Poorly designed prosthesis − not allowing access for plaque control; 
• Rough implant surface − increased risk of plaque accumulation if exposed; 
• Xerostomia. 
<ch2/1>Host susceptibility 
• Previous or current history of periodontally involved teeth; 
• Genetic susceptibility; 
• Uncontrolled Diabetes; 
• Previous or current history of smoking; 
• Radiotherapy; 
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• Medications affecting bone metabolism; 
• Presence of autoimmune oral disease; 
• Thin gingival biotypes; 
• Poor bone quality; 
• Parafunction and bruxism. 
<ch2/1>Assessment THIS IS A HEADING SAME AS RISK FACTORS  <ch1/1>? 
Early signs of peri-implant disease can be difficult to detect.32 The importance 
of regular supporting maintenance appointments in preventing and managing 
peri-implant disease has been well reported in the literature.33−35 Sustained and 
repeated contact with patients enables clinicians to modify and reinforce oral 
hygiene, provide prophylactic care and recognize signs of developing disease so 
that treatment can be initiated at an early stage.36 Assessment should focus on 
detecting the presence or absence of plaque accumulation, bleeding, 
suppuration, and clinical or radiographic bone loss. 
<ch2/1>Plaque accumulation 
There is a significant dose-dependent association between plaque scores and 
peri-implant disease37,38 and should always be evaluated.39 Plaque control around 
implants is difficult to achieve.38 The prosthetic structure must be designed to 
allow access for oral hygiene at the implant site. Failure to do this may 
predispose to plaque accumulation and peri-implant disease.40 This problem can 
be minimized by constructing a suprastructure that makes it easy for the 
patient to perform oral hygiene. In some instances, it may be necessary to 
modify or replace existing prosthetic supra-structures to allow access for 
cleaning.41 Provisional prostheses are useful in trialling designs and oral hygiene 
in addition to the prerequisite for impeccable oral hygiene prior to implant 
planning. Whenever possible, margins of implant-supported prostheses should be 
placed at or above the peri-implant mucosal margin to facilitate access for 
biofilm control. The intracoronal compartments of screw-retained fixed 
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restorations, internal implant cavities, and the microgap at the abutment-
implant interface are heavily contaminated.42 Rough surfaces collect more 
biofilm than smooth surfaces and are more difficult to clean once exposed.28 
Extruded cement in the subcrevicular peri-implant space can be challenging to 
clean up and remove. It will act as a nidus for biofilm accumulation and result in 
an inflammatory lesions.43 Therefore, only a small amount of radio-opaque 
cement has been suggested to be used, placed around the rim of the prosthesis, 
which might then be seated on an abutment replica to remove any large excess 
prior to cementation. Limiting the gingival extent of the crown to no more than 
1.5 mm beyond the gingival margin  may provide some protection;3,6 restorations 
should be cemented on individualized abutments allowing proper cement 
removal(12) 
The amount of keratinized tissue may negatively influence treatment outcomes 
and the patient’s ability to maintain adequate plaque control due to discomfort 
when performing oral hygiene.44 Sites with less than 2 mm thickness of 
keratinized mucosa might be more disposed to plaque accumulation therfore.45 
However, the presence of keratinized mucosa to maintain peri-implant health 
does not seem to be necessarily essential in patients who are able to maintain 
adequate plaque control and are enrolled in long-term regular supportive 
therapy.46 
Mechanical biofilm control by patient and professional must be considered 
during implant planning and prosthesis design. Oral hygiene measures must be 
individually adapted to patients, evaluated and reinforced through attendance 
on a regular supportive review programme. 
<ch2/1>Peri-implant probing depth 
In the periodontium, probing is met with resistance from the connective tissues 
at the base of the sulcus in health, which prevents the probe from reaching the 
apical portion of the epithelial tissue. In disease, the resistance is reduced and 
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the probe extends further to the base of the cell infiltrate. Less resistance 
exists to probing the peri-implant sulcus in health due to the orientation of 
connective tissue fibres and lack of insertion into the implant or abutment 
surface.47 In disease, greater penetration of the peri-implant tissues can be 
expected and the probe may reach the alveolar crest.48 Use of consistent, light 
forces (0.25 N) have been advised but is challenging to produce clinically. 
Probing error is greater around implants with peri-implant disease than in health 
and when compared to probing conditions around teeth but, despite this, recent 
working groups have advocated peri-implant probing.49 
Peri-implant probing should be performed to determine the location of the base 
of a pocket relative to a known and documented fixed landmark. Conventional 
probing does not appear to damage the peri-implant tissues or implant surface.50 
Although usually between 2−4 mm, the depth of placement, mucosal biotype, as 
well as presence and contour of the prosthetic reconstruction, may increase 
probing depth readings around dental implants.51 The finding of a probing depth 
of 5 mm or more should therefore be further assessed, however, this cannot be 
seen as a sign of pathology when taken alone, but rather must be used in 
combination with other assessment parameters.  Evidence of increasing probing 
depth compared to previous findings is a more convincing measure of loss of 
attachment and bone loss than a single reading on one occasion. 
<ch2/1>Bleeding on probing 
Assessment of mucosal inflammation is primarily made by observing bleeding 
following light probing. Bleeding on probing is thought to be diagnostic of peri-
implant mucositis. The presence of bleeding on probing may not indicate the 
presence of acute inflammation in the peri-implant mucosa,52 but may be due to 
the scar tissue–implant interface or forceful probing. As with periodontitis, it is 
the absence of bleeding on probing which has a high negative predictive value 
for peri-implant disease, and is a good prognostic indicator.53 
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<ch2/1>Swelling or suppuration 
Swelling and/or suppuration implies the presence of inflammation and infection 
at the implant site. Suppuration in particular is most likely to occur where there 
is peri-implant crestal bone loss18 and has been detected in 30% of the patients 
or 17% of implants.52 
<ch2/1>Mobility 
Implant mobility is a concerning finding which suggests complete loss of direct 
bone-implant contact. Mobility should be checked for all free-standing implants, 
but routine removal of fixed prosthesis to facilitate this is not advisable, 
especially in the absence of other findings. Mobility is a terminal clinical sign 
requiring removal of the implant.51 
<ch2/1>Radiographs 
The normal bone remodelling processes will result in marginal bone loss following 
initial loading, in the region of 0.5−2 mm.22,54 It is recommended that a baseline 
radiograph is taken after connection of the definitive transmucosal structure to 
establish the level of the supporting bone.55 This provides a reference for 
comparison to radiographs at future assessments should there be clinical 
suspicion of peri-implant bone loss.6 Panoramic radiographs are not suitable for 
this comparison as the image produced is less likely to be consistent. Intra-oral 
long-cone periapical radiographs are the appropriate choice, which enables 
measurement of interproximal loss of bone from fixed reference points, such as 
implant shoulder or implant threads. Vertical bone loss of less than 0.2 mm 
annually following the implant’s first year of service has been proposed as one 
of the major criteria for success, but this amount is difficult to determine by 
visual inspection of radiographs in the clinical setting. If no previous data are 
available, over 3 mm bone loss is considered evidence of peri-implantitis. 
Radiographic evaluation of crestal bone levels over time is a reliable tool for 
identifying peri-implantitis.55 However, radiographs cannot be taken at every 
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recall visit due to concerns regarding radiation exposure. A sensible protocol 
would be that radiographs are taken after the first year, and biannually 
thereafter, extending up to 5 year intervals, or in the presence of clinical signs 
or symptoms of disease. 
<ch1/1>Summary 
The diagnosis of peri‐implant diseases require assessment of multiple diagnostic 
parameters and should be based on clinical signs of inflammatory disease. The 
rate of progression of peri-implant disease is usually more aggressive and 
occurs at a more rapid rate than periodontitis. As for patients susceptible to 
periodontal disease, establishing effective home care with regular supportive 
professional maintenance appointments is essential for long-term survival. 
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